Cosmetic Surgery Market Share

Cosmetic Surgery Market Overview

The Cosmetic Surgery market size was valued at USD 56.02 billion in 2023 and projected to grow from USD 60.22 billion in 2024 to USD 108.65 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.65% during the forecast period (2024 - 2032). The development of innovative aesthetic devices by manufacturers has resulted in an upsurge in demand for aesthetic treatments in recent years.

The advent of technologically improved products, such as non-invasive body sculpting devices that employ fat freezing technology, for example, is likely to provide attractive growth prospects. The desire to seem young has fueled demand for cosmetic surgeries in emerging countries.

The debut of AvéliTM, a revolutionary new cellulite device, has been announced by Revelle Aesthetics, Inc., a Silicon Valley MedTech business funded by venture capital. The company is focused on inventing precision solutions that attack the underlying cause of women's most irritating aesthetic concerns in 2022. The goal of Revelle is to create intelligent, aesthetically pleasing solutions that give practitioners dependable results and significant results for women. At the annual plastic surgery conference of The Aesthetic Society, the company recently unveiled Avéli, an FDA-cleared device that temporarily diminishes the appearance of cellulite on the buttocks and thighs in a single procedure.

In 2018, a chain of dermatological and plastic surgery centers received approval from the Drug Controller General of India (DCGI) — The Esthetic Clinics, which conducts clinical studies and drug research for cosmetology, cosmetic surgery technologies, and pharmaceuticals for skin, hair, and other plastic surgery conditions in India. The program will lower the cost of product testing while facilitating the quicker release of more advanced, cutting-edge cosmetic, dermatological, and plastic surgery goods. The benefit to Indian pharmaceutical businesses is that they will be able to conduct trials without having to travel overseas because they will have access to high-quality research facilities, clinicians, and laboratories within India.

Further, in October 2022, VOLUX XC of Abbive Inc., under its Juvéderm filler range, received FDA approval. It is a highly cohesive hyaluronic acid gel filler. Jawline improvement encompasses the chin and jaw region, and this Juvederm filler was the sixth product to be launched within this category. Liposuction, breast augmentation, nose reshaping, among others, are some of the popular aesthetic procedures that are invasive. The demand for invasive procedures has increased due to the growing focus on physical appearance.

For example, in August 2022, Airsculpt Technologies introduced an FDA-approved cellulite removal tool called AirSculpt Smooth. A stubborn cellulite dimple can be eliminated with air sculpt smooth technology. Without scalpels, stitches or needles in place, it is done while awake so that patients may get back to normal activities within 24 to 48 hours.

In June 2022 Cynosure announced the latest addition to its PicoSure system called PicoSure Pro device. Picosure pro device uses a pressurized delivery mechanism to provide skin revitalization and unwanted pigmentation treatments that can work on all types of skins.

In another instance, in June 2022, Vision Source, located at Lakewood Ranch, Florida, launched an in-house medical spa offering facial services and aesthetics. The med spa offers antiaging aesthetic treatments as well as skin rejuvenation.

Expanding into the United States by welcoming Dr Steven Dayan, a top facial plastic surgeon and his Chicago-based team who joined MedSpa Partners’ top-tier medical aesthetics platform was done April 2022 by MedSpa Partners Inc.

Cutera’s AviClear became the first laser indicated for acne treatment approved by the Food and Drug Administration (FDA) in 2022. In clinical research using AviClear, acne was significantly reduced within three sessions of thirty minutes each.

For instance, Allergen Aesthetics, a subsidiary of AbbVie Inc., introduced Coolsculpting Elite, their next-generation fat reduction system with applicators designed to fit the natural curves of the body in 2021.

May 2024: AbbVie received FDA approval for its new line of injectable dermal fillers, expanding its portfolio in the cosmetic surgery market. The new fillers are designed to offer enhanced longevity and natural-looking results.

April 2024: Cynosure introduced its latest laser technology, promising enhanced precision and reduced downtime for patients. The new system integrates advanced cooling mechanisms to improve patient comfort.

Cosmetic Surgery Market Trends

• Growing demand for cosmetic surgeries and minimally invasive procedures fuels market growth

Cosmetic surgery and minimally invasive procedures such as botulinum toxin and face filler injections have grown in popularity over the last decade. Over the last few years, Americans have been spending more money on cosmetic surgery. Moreover, market participants are routinely developing technologically sophisticated products, which may boost segmental expansion throughout the forecast period. For instance, Revance (US), launched the RHA (resilient hyaluronic acid) filler line in August 2020. The resilient hyaluronic acid fillers are meant to adjust to face dynamics and are the initial stage in a range of treatments for aesthetic practices. Such factors, together with technical improvements in equipment and rising awareness about cosmetic surgery, are likely to drive the market of cosmetic surgery throughout the forecast period.

Cosmetic Surgery Market Segment Insights

Cosmetic Surgery Procedure Type Insights

The Market segments of Cosmetic Surgery, based on procedure type, includes invasive and non-invasive. The invasive segment is further bifurcated into breast augmentation, liposuction, nose reshaping, eyelid surgery, tummy tuck, and others. Furthermore, the non-invasive segment is further bifurcated into Botox injections, soft tissue fillers, chemical peel, laser hair removal, microdermabrasion, dermabrasion, and others. The non-invasive segment held the majority share in the market in 2022. Technological improvements in innovations, rising demand for invasive and non-invasive treatments, and rising awareness of cosmetic surgery are the primary drivers driving market growth. According to the most recent American Society of Plastic Surgeons (ASPS) data updated in February 2022, a total of 13,281,235 cosmetic minimally invasive procedures were performed in the US in 2020, with botulinum toxin remaining the most popular procedure with 4.4 million procedures, followed by soft tissue filler (3.4 million) and Laser Skin Resurfacing (9,97,245). As a result, the rising popularity of cosmetic treatments for face augmentation is the primary market driver.

Cosmetic Surgery End User Insights

The Cosmetic Surgery Market segmentation, based on end user, includes hospitals and dermatology clinics, ambulatory surgical centers, and others. The hospitals and dermatology clinics segment dominated the market in 2022. Cosmetic surgical treatments are typically performed in a hospital setting where all other supplementary facilities are accessible, which serves as a driving factor in the market. For instance, according to Plastic Surgery Report 2020, a total number of 2,803,625 cosmetic procedures were performed in the hospitals and 6,945,842 were performed in free-standing ambulatory surgical facility.

Figure 2: Cosmetic Surgery Market, by End User, 2022 & 2030 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Cosmetic Surgery Regional Insights

By Region, the study segments the market into North America, Europe, Asia-Pacific, and Rest of the World. The North America cosmetic surgery market accounted for the largest market share in 2022, due to the developed healthcare infrastructure, a high number of surgeries performed in the region, and the presence of major key players in the region such as AbbVie (US), Cynosure (US), Solta Medical (US), and Candela Corporation (US), are some factors driving growth for the North America cosmetic surgery market. According to Aesthetic Plastic Surgery Statistics, surgical procedures climbed by 54%, while non-surgical surgeries increased by 44%. In 2021, the typical plastic surgeon conducted 320 surgical procedures, up from 220 in 2020. Additionally, in 2021, 365,000 breast augmentations were performed (+44%).  Furthermore, 148,000 women had their implants removed and replaced (+32% from 2020), whereas 71,000 had their implants removed but not replaced (+47%).

Further, the major countries will be study are: The US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3: COSMETIC SURGERY MARKET BY REGION 2022 & 2030

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe cosmetic surgery market accounted for the second-largest market share due to technology advancements, increasing healthcare expenditure, and increasing prevalence of skin diseases. For instance, according to the British Association of Aesthetic Plastic Surgeons (BAAPS), approximately 27,000 operations were performed in 2019, with breast augmentation being the most popular procedure. Furthermore, the Germany cosmetic surgery attributed to hold the largest market share, and the France cosmetic surgery is projected be the fastest growing market in the Europe region.

The Asia-Pacific cosmetic surgery market is expected to be the fastest growing from 2023 to 2030 owing to countries such as China, India, and South Korea which support the region. South Korea is known as a cosmetic surgery hub, which aids industry growth. The availability of technologically sophisticated items, as well as the increased emphasis on physical attractiveness, are expected to drive the regional market. Moreover, China cosmetic surgery accounted to hold the largest market share, and the India cosmetic surgery is projected to be the fastest growing market in the Asia-Pacific region.

Cosmetic Surgery Key Market Players & Competitive Insights

Major market players R&D investments, rising number of skin diseases, and improved product quality, and the rise in per capita income of the consumers make the cosmetic surgery market lucrative. To expand their reach and optimize their operating costs, the major players focus on obtaining regulatory authorizations from government agencies for their products and emphasize acquisitions and product launches to gain a substantial market share.

The debut of AvéliTM, a revolutionary new cellulite device, has been announced by Revelle Aesthetics, Inc., a Silicon Valley MedTech business funded by venture capital. The company is focused on inventing precision solutions that attack the underlying cause of women's most irritating aesthetic concerns in 2022. The goal of Revelle is to create intelligent, aesthetically pleasing solutions that give practitioners dependable results and significant results for women. At the annual plastic surgery conference of The Aesthetic Society, the company recently unveiled Avéli, an FDA-cleared device that temporarily* diminishes the appearance of cellulite on the buttocks and thighs in a single procedure.

In 2018, a chain of dermatological and plastic surgery centers received approval from the Drug Controller General of India (DCGI) — The Esthetic Clinics, which conducts clinical studies and drug research for cosmetology, cosmetic surgery technologies, and pharmaceuticals for skin, hair, and other plastic surgery conditions in India. The program will lower the cost of product testing while facilitating the quicker release of more advanced, cutting-edge cosmetic, dermatological, and plastic surgery goods. The benefit to Indian pharmaceutical businesses is that they will be able to conduct trials without having to travel overseas because they will have access to high-quality research facilities, clinicians, and laboratories within India.

AbbVie, Inc. (AbbVie) is a global, research-based biopharmaceutical company specializing in manufacturing and marketing well-known brands such as Humira and Imbruvica. The company manufactures, develops, and commercializes pharmaceutical products and biological products for patients worldwide. It has a comprehensive product portfolio that has leadership positions in key therapeutic areas of immunology, hematologic oncology, neuroscience, eye care, and women's health. It creates next-generation gene therapies for patients who need them and whose illnesses could benefit. It is committed to discovering and delivering a constant supply of innovative new medicines with distinct and compelling benefits in more than 70 countries worldwide.

Candela is a medical aesthetic device company. The company's technologies enable physicians to provide advanced energy-based solutions for a broad range of medical aesthetic applications including treatment of benign vascular and pigmented lesions, scars, facial resurfacing, wrinkle reduction, acne, leg veins, cellulite, body shaping, women's health, and tattoo and hair removal. It is the legal producer of multiple products branded under the Candela name including the Profound, CO2RE, CO2RE Intima, UltraShape, elōs plus, eTwo, VelaShape system families.

Moreover, In February 2023, Candela Introduced the new FDA-cleared Profound Matrix System. This multi-application solution, designed to repair, preserve, and restore skin at various stages of ageing, includes Sublime, Sublative RF, and all-new Matrix Pro applicators.

Key Companies in the cosmetic surgery market includes.

• AbbVie (US)


• Cynosure (US)


• Evolus Inc. (US)


• Gladerma (Switzerland)


• REVANCE AESTHETICS (US)


• Lumenis (Israel)


• Solta Medical (US)


• Candela Corporation (US)


• Alma Laser (Israel)


• Cutera (US)


• Sientra, Inc. (US)


• Fotona (Europe)


• Johnson & Johnson Services, Inc. (US)

Cosmetic Surgery Industry Developments

• 
  

  In February 2023, Candela Corporation introduced the new FDA-cleared Profound Matrix System. This multi-application solution, designed to repair, preserve, and restore skin at various stages of ageing, includes Sublime, Sublative RF, and all-new Matrix Pro applicators.

  
  


• 
  

  In June 2022, Cynosure introduced the PicoSure Pro device, the newest improvement to the PicoSure platform.

  
  


• 
  

  In March 2022, Health Canada has given its approval for Sientra breast implants. Through its local partner Kai Aesthetic, the company will offer breast implants in Canada. Sientra will uphold the highest quality, safety, and service standards for patients and plastic surgeons within the terms of the distribution agreement.

  
  


• 
  

  In September 2021, Galderma's Restylane portfolio grew and expanded. Restylane Eyesight was introduced as a focused treatment for under-eye shadows. The FDA authorized Restylane Defyne in February 2021 for the augmentation and treatment of mild to moderate chin retrusion in people over the age of 21.

  
  


• 
  

  The World Health Organization, also known as the WHO, is urged by US and Mexican authorities to declare an international health emergency due to a fungal epidemic linked to cosmetic procedures in Mexico. According to the Centers for Disease Control and Prevention, or CDC, meningitis claimed the lives of two patients who underwent surgeries under epidural anesthesia. Nearly 400 people are being watched in the United States and Mexico. In the Mexican town of Matamoros, two cosmetic surgery clinics have closed. Authorities in the US and Mexico have advised people to get evaluated, even if they are asymptomatic, if they had procedures involving anesthesia with epidural performed at the River Side Surgical Center or Clinica K-3 since January.

  
  


• 
  

  A law that aims to control influencers' commercial activities and safeguard consumers from fraud and scams is being finalized in France. The National Assembly and the Senate have already approved the rule forbidding promoting cosmetic surgery and paying for sports betting subscriptions. Influencers must also disclose how much they have been compensated for advocating a product, whether photos have been edited, and whether artificial intelligence was used to create a person's face or body. If someone violates the rules, they could spend a maximum of two years in jail, pay a fine of €300,000 ($320,000), and lose their right to use social media for business purposes. The legislators use examples like advertising alleged "drugs" for cancer or hair-loss-inducing cosmetics. The proposed law expands on existing French law, which strictly controls the promotion of goods like alcohol and tobacco. While the new bill might call for influencers to incorporate a display indicating which post is being sponsored, the existing law already requires advertising to be transparent.

  
  

Cosmetic Surgery Segmentation

Cosmetic Surgery Procedure Type Outlook

• Invasive
  
  
  
  • Breast Augmentation
    
    
    
    • Breast Implants
      
      
      
      • Silicone Breast Implants
      
      
      • Saline Breast Implants
      
      
      • Smooth Breast Implants
      
      
      • Others
      
      
      
      
    
    
    • Fat Transfer Augmentation
    
    
    
    
  
  
  • Liposuction
    
    
    
    • Tumescent Liposuction
    
    
    • Ultrasound-Assisted Liposuction
    
    
    • Laser-Assisted Liposuction
    
    
    
    
  
  
  • Nose Reshaping
    
    
    
    • Turbinate Reduction
    
    
    • Septoplasty
    
    
    • Rhinosseptoplasty
    
    
    • Rhinoplasty
    
    
    
    
  
  
  • Eyelid Surgery
    
    
    
    • Upper Blepharoplasty
    
    
    • Lower Blepharoplasty
    
    
    • Bilateral Eyelid Surgery
    
    
    • Double Eyelid Surgery
    
    
    • Transconjunctival Eyelid Surgery
    
    
    
    
  
  
  • Tummy Tuck
    
    
    
    • Full Tummy Tuck
    
    
    • Mini Tummy Tuck
    
    
    • Extended Tummy Tuck
    
    
    • Others
    
    
    
    
  
  
  • Others
  
  
  
  


• Non-Invasive
  
  
  
  • Botox Injections
    
    
    
    • Type A
    
    
    • Type B
    
    
    
    
  
  
  • Soft Tissue Fillers
  
  
  • Chemical Peel
    
    
    
    • Glycolic Chemical Peel
    
    
    • Lactic Peel
    
    
    • Retinol Peel
    
    
    • Others
    
    
    
    
  
  
  • Laser Hair Removal
  
  
  • Microdermabrasion
    
    
    
    • Diamond Microdermabrasion
    
    
    • Crystal Microdermabrasion
    
    
    
    
  
  
  • Dermabrasion
  
  
  • Others
  
  
  
  

Cosmetic Surgery End User Outlook

• Hospitals and Dermatology Clinics


• Ambulatory Surgical Centers


• Others

Cosmetic Surgery Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America